Fragility Fractures of the Pelvis (FFP)NCT07871084
Functional Outcomes in Older Adults With Fragility Fractures of the Pelvis: The FFP-France Study
An observational study of Fragility Fractures of the Pelvis (FFP) and Osteoporotic Fractures, run by Centre Hospitalier Universitaire de Nice at 1 site in France.
Trial summary
Fragility fractures of the pelvis (FFP) are an increasingly common complication of osteoporosis in older adults and are associated with substantial morbidity, loss of independence, and mortality. Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Fragility Fractures of the Pelvis (FFP), Osteoporotic Fractures
- What is being tested?
- Observational Assessment of Fragility Fractures of the Pelvis
- How many people
- 200 participants
- Where
- 1 siteFrance
- Study dates
- 1 Dec 2026to 30 Nov 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adults aged 60 years and older diagnosed with a fragility fracture of the pelvis and managed at participating French centers during the retrospective or prospective study periods.
Who may be able to join
- Age ≥60 years.
- Fragility fracture of the pelvis occurring spontaneously or following a low energy trauma.
- Fracture confirmed by imaging (radiography, computed tomography, magnetic resonance imaging, bone scintigraphy, or positron emission tomography).
Who cannot join
- Pelvic fracture resulting from high-energy trauma.
- Pathological fracture secondary to a malignant bone lesion.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site
CHU de Nice
Nice, Alpes Maritimes, 06000
Marie-Charlotte TROJANI, 0492549777 ext. +33, marie-charlotte.trojani@univ-cotedazur.fr
About this study
Official title: Functional Outcomes, Management, and Prognostic Factors in Older Adults With Fragility Fractures of the Pelvis: A French Multicenter Ambispective Observational Study
Fragility fractures of the pelvis (FFP) are an increasingly common complication of osteoporosis in older adults and are associated with substantial morbidity, loss of independence, and mortality. Despite their clinical impact, FFP remain underdiagnosed, particularly sacral fractures, and their management varies considerably across centers.FFP-France is a French multicenter ambispective observational study designed to describe functional outcomes in adults aged 60 years and older with FFP. The primary objective is to assess functional outcome at 6 months using the Parker Mobility Score. Secondary objectives include describing clinical and radiological characteristics, diagnostic and therapeutic management, pain, autonomy, mortality, osteoporosis management, and factors associated with unfavorable functional recovery.
- Being tested
- Observational Assessment of Fragility Fractures of the Pelvis
- Medical subject headings
- Osteoporotic Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Observational Assessment of Fragility Fractures of the PelvisOther
No study-specific intervention is performed. Diagnostic and therapeutic management is determined by routine clinical practice at each participating center. Clinical, radiological, treatment, and outcome data are collected for observational purposes.
| Study group | Role | What they receive |
|---|---|---|
| Patients With Fragility Fractures of the Pelvis | Not described Receives: Other: Observational Assessment of Fragility Fractures of the Pelvis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Functional Mobility at 6 Months Assessed by the Parker Mobility Score (PMS)
Functional mobility will be assessed using the Parker Mobility Score (PMS), which evaluates the participant's ability to walk indoors, walk outdoors, and go shopping. Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 9, with higher scores indicating greater mobility.
Measured: 6 months after the fragility fracture of the pelvis
Secondary outcomes (4)
Type of Fracture Management
Proportion of patients managed conservatively or interventionally for fragility fracture of the pelvis. Management strategies will be described according to patient characteristics and fracture type, including the Rommens classification
Measured: From diagnosis to 12 months after the fracture
Use of Anti-Osteoporotic Treatment
Proportion of patients receiving anti-osteoporotic treatment after the fracture. Anti-osteoporotic treatment before and after the fracture, including treatment initiation, continuation, or modification during follow-up, will be recorded.
Measured: From diagnosis to 12 months after the fracture
Recovery of Pre-Fracture Mobility
Proportion of patients who recover their pre-fracture level of mobility at 3 and 12 months, based on the Parker Mobility Score. The Parker Mobility Score ranges from 0 to 9, with higher scores indicating better mobility. Demographic and clinical characteristics, fracture type, fracture management strategy, and osteoporosis management will be investigated as potential factors associated with functional recovery.
Measured: 3 and 12 months after the fracture
All-Cause Mortality
Proportion of patients who die from any cause during follow-up. Mortality will be assessed at 3, 6, and 12 months after the fracture
Measured: 3, 6, and 12 months after the fracture
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Oct 2026
- Study start1 Dec 2026 (estimated)
- Primary completion31 May 2029 (estimated)
- Study completion30 Nov 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Fragility Fractures of the Pelvis (FFP)Studies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de NiceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07871084
- Sponsor's protocol ID
- 26Rhumato02
- Status last verified
- Oct 2026
- First submitted
- 7 Oct 2026
- Last updated
- 13 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Functional Outcomes, Management, and Prognostic Factors in Older Adults With Fragility Fractures of the Pelvis: A French Multicenter Ambispective Observational Study
- ClinicalTrials.gov ID
- NCT07871084
- Acronym / sponsor ID
- 26Rhumato02
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire de NiceUniversity, hospital or other
- Study start
- 1 Dec 2026 (estimated)
- Primary completion
- 31 May 2029 (estimated)
- Study completion
- 30 Nov 2029 (estimated)
- First posted
- 13 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Fragility fractures of the pelvis (FFP) are an increasingly common complication of osteoporosis in older adults and are associated with substantial morbidity, loss of independence, and mortality. Despite their clinical impact, FFP remain underdiagnosed, particularly sacral fractures, and their management varies considerably across centers.FFP-France is a French multicenter ambispective observational study designed to describe functional outcomes in adults aged 60 years and older with FFP. The primary objective is to assess functional outcome at 6 months using the Parker Mobility Score. Secondary objectives include describing clinical and radiological characteristics, diagnostic and therapeutic management, pain, autonomy, mortality, osteoporosis management, and factors associated with unfavorable functional recovery.
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients With Fragility Fractures of the Pelvis | – | Other: Observational Assessment of Fragility Fractures of the Pelvis |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adults aged 60 years and older diagnosed with a fragility fracture of the pelvis and managed at participating French centers during the retrospective or prospective study periods.
Key inclusion criteria (3 listed)
- Age ≥60 years.
- Fragility fracture of the pelvis occurring spontaneously or following a low energy trauma.
- Fracture confirmed by imaging (radiography, computed tomography, magnetic resonance imaging, bone scintigraphy, or positron emission tomography).
Key exclusion criteria (2 listed)
- Pelvic fracture resulting from high-energy trauma.
- Pathological fracture secondary to a malignant bone lesion.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Observational Assessment of Fragility Fractures of the PelvisNo study-specific intervention is performed. Diagnostic and therapeutic management is determined by routine clinical practice at each participating center. Clinical, radiological, treatment, and outcome data are collected for observational purposes. | Other | Patients With Fragility Fractures of the Pelvis |
Primary outcome
Functional Mobility at 6 Months Assessed by the Parker Mobility Score (PMS)
Time frame: 6 months after the fragility fracture of the pelvis
Functional mobility will be assessed using the Parker Mobility Score (PMS), which evaluates the participant's ability to walk indoors, walk outdoors, and go shopping. Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 9, with higher scores indicating greater mobility.
4 secondary outcomes
Type of Fracture Management
Time frame: From diagnosis to 12 months after the fracture
Use of Anti-Osteoporotic Treatment
Time frame: From diagnosis to 12 months after the fracture
Recovery of Pre-Fracture Mobility
Time frame: 3 and 12 months after the fracture
All-Cause Mortality
Time frame: 3, 6, and 12 months after the fracture
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Oct 2026.
Related trials for Fragility Fractures of the Pelvis (FFP)
Active, not recruitingObservational study
Fragility Fractures of the Pelvis (FFP)
Pelvic Fracture
Not yet recruiting
Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery for FFP3-4 Fragility Fractures of the Pelvis in Elderly Patients
Fragility Fractures of the Pelvis (FFP), Osteoporosis
Not yet recruiting
Robot Assisted Minimally Invasive Treatment Versus Conservative Treatment for Fragility Fractures of the Pelvis Type 1-2 in Elderly Patients
Fragility Fractures of the Pelvis (FFP)
RecruitingObservational study
Assessment of Treatment Variability for Pelvic Ring Fragility Fractures
Pelvic Fractures, Fragility Fractures of the Pelvis (FFP)
Not yet recruitingObservational study
A Snapshot Audit of Traumatic Pelvic Ring Injuries
Pelvic Trauma, Pelvic Fracture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Fragility Fractures of the Pelvis (FFP) and Osteoporotic Fractures, run by Centre Hospitalier Universitaire de Nice at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Marie-Charlotte TROJANI (0492549777 ext. +33, marie-charlotte.trojani@univ-cotedazur.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Functional Mobility at 6 Months Assessed by the Parker Mobility Score (PMS) (time frame: 6 months after the fragility fracture of the pelvis). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.